Welcome to our dedicated page for Akoya Biosciences SEC filings (Ticker: AKYA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Akoya Biosciences, Inc. filings document the formal record of the former Nasdaq-listed spatial biology company, including its common stock registration, stockholder voting matters and material event disclosures. The filing record includes 8-K disclosures for a special meeting of stockholders and the completed merger in which Akoya survived as a wholly owned subsidiary of Quanterix.
Akoya’s SEC record also includes a Form 25 notification for removal of its common stock from listing and registration on Nasdaq. Related filings document governance matters, capital-structure information, emerging growth company status, transaction disclosures and the regulatory steps associated with the company’s transition from a standalone public issuer.